UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                   FORM 10-Q/A

[X]  Amendment to Quarterly report pursuant to Section 13 or 15(d) of the
     Securities Exchange Act of 1934 for the quarterly period ended April 3,
     1999 or

[ ]  Transition report pursuant to Section 13 or 15(d) of the Securities
     Exchange Act of 1934 for the transition period from _____________ to
     _____________.

                         Commission file number 0-17885

                        BEI MEDICAL SYSTEMS COMPANY, INC.
             (Exact name of Registrant as specified in its charter)

        Delaware                                        71-0455756
-----------------------                     ----------------------------------
(State of incorporation)                   (I.R.S. Employer Identification No.)



                               100 Hollister Road
                           Teterboro, New Jersey 07608
                           ---------------------------
                    (Address of principal executive offices)


                                 (201) 727-4900
                         (Registrant's telephone number)


Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  Registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

                                    Yes _X_  No ___

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date.

        Common Stock: $.001 Par Value, 7,687,596 shares as of May 1, 1999


                                       1
<PAGE>

               BEI MEDICAL SYSTEMS COMPANY, INC. AND SUBSIDIARIES

                                      INDEX


                                                                
                                                                
                                                                
PART II.  OTHER INFORMATION                                     
          -----------------                                     
                                                                
Item 6.   Exhibits and Reports on Form 8-K                      
                                                                
          (a)  Exhibits
                                                                
               27.1 Financial Data Schedule

                                                                
          SIGNATURES                                            
          ----------                                            



                                       2
<PAGE>


                                   SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized on May 21, 1999.



                             BEI Medical Systems Company, Inc.


                             By:   /s/ Thomas W. Fry                  
                                   ---------------------------------------------
                                   Thomas W. Fry
                                   Vice President of Finance and Administration,
                                   Secretary and Treasurer
                                   (Chief Financial Officer)


                                        3